Charlotte Schubert
Charlotte Schubert is a GeekWire contributing writer focused on biotech, healthcare, and life sciences; she is a Seattle native with a Ph.D. in developmental biology.
Seattle Hub for Synthetic Biology Secures $10M Grant to Advance DNA Recording Technology for Disease Research
The Seattle Hub for Synthetic Biology received a $10 million grant from the Washington Research Foundation to support training scientists and launching biotech startups developing DNA recording technology for studying diseases. This initiative, launched in January 2024, is a collaboration between the Allen Institute, the Chan Zuckerberg Initiative, and the University of Washington.
GeekWire Names Adaptive Biotechnologies, Blink, Helion, Impinj, and Treasury4 as 2023 Workplace of the Year Finalists
The 2023 GeekWire Awards announced five finalists for Workplace of the Year—Adaptive Biotechnologies, Blink, Helion, Impinj, and Treasury4—highlighting their employee-friendly policies amid recent challenges. Winners will be revealed on May 18 following community voting and judge evaluations.
Icosavax IPO: Seattle biotech raises $180M, stock jumps 200% on first trading day (ICVX)
Seattle biotech Icosavax surged more than 200% on its NASDAQ debut after raising over $180 million by pricing shares at $15; the company develops virus-like particle vaccines and recently began phase 1/2 trials for a COVID-19 vaccine supported by a $10 million Gates Foundation grant.
Organizations
-
GeekWire Contributing Writer · current
